Tradestie Institutional Equity Comparison Engine

FBLG vs VENU โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

FBLG Overall Edge

FBLG Captures Institutional Edge (2โ€“1 Pillars ยท 4โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to FibroBiologics, Inc. Common Stock (FBLG) driven by superior Growth & Margin, Momentum & Technical while VENU counters with relative strength in Options & Structure. Fundamentally, FBLG trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus VENU at N/M Forward P/E and -294.7% operating margin (+2.9% YoY). In options structure, FBLG sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against VENU sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
FBLG N/M vs VENU N/M Fwd P/E
Growth & Margin Winner FBLG
Op Margin 0.0% vs -294.7% ยท YoY +0.0% vs +2.9%
Momentum & Technical Winner FBLG
1Y +104.6% vs -89.8% ยท 52W Pos 14% vs 1%
Options & Structure Winner VENU
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (<1st %ile IV)
FBLG NASDAQ
FibroBiologics, Inc. Common Stock
Pharmaceutical Preparations
$0.70
-15.06% 1D
Market Cap $7.5M
1M Return -30.88%
1Y Return +104.64%
Forward P/E N/M
Unified AI Score
41.0 / 100 SELL
Tech 25.0 Fund 46.0 Flow 50.0 Mom 55.0
VENU NYSE American
Venu Holding Corporation
Services-Amusement & Recreation Services
$0.99
-3.6% 1D
Market Cap $58.3M
1M Return -23.03%
1Y Return -89.81%
Forward P/E N/M
Unified AI Score
42.3 / 100 HOLD
Tech 33.0 Fund 51.0 Flow 55.0 Mom 45.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: FBLG +104.64% VENU -89.81% Spread: +194.45 pp (FBLG Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
FBLG TTM Op. Margin: 0.0% VENU TTM Op. Margin: -294.7%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on FBLG vs VENU. Trailing 12-month operating profitability (FBLG 0.0% vs VENU -294.7%) and valuation multiples (FBLG N/M vs VENU N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: FBLG (4) vs VENU (4)
Institutional Metric FBLG VENU Criterion Row Winner
Market Capitalization Scale $7.5M $58.3M Larger Scale VENU
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +0.0% +2.9% Higher Growth VENU
Operating Margin (TTM) Profitability 0.0% -294.7% Higher Margin FBLG
Net Profit Margin Profitability 0.0% -281.4% Higher Margin FBLG
Return on Equity (ROE) Capital Efficiency -1696.9% -24.9% Higher ROE VENU
52-Week Range Position Momentum 14% ($0โ€“$4) 1% ($1โ€“$11) Stronger Trend FBLG
Beta / 30D Volatility Risk Regime -2.17ฮฒ ยท 68% Vol 1.72ฮฒ ยท 86% Vol Lower Realized Risk FBLG
Unified Institutional Score Composite Signal 41.0 / 100 (SELL) 42.3 / 100 (HOLD) Higher Composite VENU

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full FBLG vs VENU Buy Guide
FBLG UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live FBLG Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
VENU UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile <1st %ile
IV Regime Compressed (<25th %ile)
Live VENU Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither FBLG nor VENU registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.